Results of a single-arm pilot study of 32P microparticles in unresectable locally advanced pancreatic adenocarcinoma with gemcitabine/nab-paclitaxel or FOLFIRINOX chemotherapy.
ESMO Open
; 7(1): 100356, 2022 02.
Article
in En
| MEDLINE
| ID: mdl-34953400
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pancreatic Neoplasms
/
Adenocarcinoma
Type of study:
Guideline
/
Prognostic_studies
Limits:
Adult
/
Humans
Language:
En
Journal:
ESMO Open
Year:
2022
Document type:
Article
Country of publication: